Skip to main content
Clinical Trials/NCT03131622
NCT03131622UnknownNot Applicable

Impact of Ibis, a Digital Health Solution for Patient Activation and Early Intervention, on Acute Care Utilization by Patients With Advanced COPD

Senscio Systems0 sites240 target enrollmentStarted: December 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
240
Primary Endpoint
Reduction in Acute Care Utilization

Study Overview

Brief Summary

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients with COPD.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Gold Stage II with a CAT Score above 19
  • •Gold Stage III/IV with a CAT Score above 14

Exclusion Criteria

  • •Cognitive or physical impediments that inhibits patients from interacting with our digital therapeutics platform.

Arms & Interventions

Digital Therapeutics

Experimental

Patients assigned to the digital therapeutics arm will receive Ibis and all the associate services.

Intervention: Digital Therapeutics (Behavioral)

Control

No Intervention

Outcomes

Primary Outcomes

Reduction in Acute Care Utilization

Time Frame: 6 months and then again at 1 year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials